Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Non-Current Assets (2016 - 2025)

Orthofix Medical's Non-Current Assets history spans 16 years, with the latest figure at $433.8 million for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets fell 5.7% year-over-year to $433.8 million, compared with a TTM value of $1.7 billion through Dec 2025, down 10.2%, and an annual FY2025 reading of $433.8 million, down 5.7% over the prior year.
  • Non-Current Assets for Q4 2025 was $433.8 million at Orthofix Medical, down from $438.4 million in the prior quarter.
  • The five-year high for Non-Current Assets was $512.0 million in Q3 2023, with the low at $202.6 million in Q4 2022.
  • Average Non-Current Assets over 5 years is $373.9 million, with a median of $436.1 million recorded in 2025.
  • Year-over-year, Non-Current Assets dropped 18.94% in 2021 and then soared 152.49% in 2023.
  • Tracing OFIX's Non-Current Assets over 5 years: stood at $207.1 million in 2021, then fell by 2.15% to $202.6 million in 2022, then skyrocketed by 149.15% to $504.9 million in 2023, then decreased by 8.89% to $460.0 million in 2024, then dropped by 5.7% to $433.8 million in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Non-Current Assets are $433.8 million (Q4 2025), $438.4 million (Q3 2025), and $441.3 million (Q2 2025).